Rothstein B. Topical JAK inhibitor Ruxolitinib for Vitiligo Treatment. J of Skin [Internet]. 2018 Dec. 17 [cited 2024 Jul. 22];2:S110-S111. Available from: https://jofskin.org/33014/index.php/skin/article/view/451